444
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Serotonergic Neurons of Dorsal Raphe Nucleus on the Effect of a Xanthone from Kielmeyera coriacea Stems in Behavioral Tests

, , , &
Pages 883-888 | Accepted 09 May 2008, Published online: 20 Jan 2009

References

  • F Artigas, L Romero, C Montigny, and P Blier. (1996). Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosc 19:378–383.
  • TMA Alves, AF Silva, M Brandão, TSM Grandi, EF Smânia, A SmâniaJr., and CL Zani. (2000). Biological screening of Brazilian medicinal plants. Mem Inst Oswaldo Cruz 95:367–373.
  • EA Audi, DG Cortez, JVC Martins, and F Otobone. (2002). Preliminary evaluation of Kielmeyera coriacea leaves extract on central nervous system. Fitoterapia 73:517–519.
  • JC Ballenger. (1993). Panic disorder: Efficacy of current treatments. Psychol Bull 29:477–486.
  • N Barnes, and T Sharp. (1999). A review of central 5-HT receptor and their function. Neuropharmacology 38:1083–1152.
  • SG Beck, YZ Pan, AC Akanwa, and LG Kirby. (2004). Median and dorsal raphe neurons are not eletrophysiologically identical. J Neurophysiol 91:994–1005.
  • V Butterweck, F Petereit, H Winterhoff, and A Nahrstedt. (1998). Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med 64:291–294.
  • F Chaouloff, O Berton, and P Mormède. (1999). Serotonin and stress. Neuropsychopharmacology 21 (2):28–32.
  • DAG Cortez, MCM Young, A Marston, L Wolfender, and K Hostettmann. (1998). Xanthones, triterpenes and a biphenyl from Kielmeyera coriacea.. Phytochemistry 47:1367–1374.
  • LA Dawson, HQ Nguyen, DI Smith, and LE Schechter. (2000). Effects of chronic fluoxetine treatment in the presence and absence of (+)pindolol: A microdialysis study. Brit J Pharmacol 130:797–804.
  • JFV Deakin, and FG Graeff. (1991). 5-HT and mechanisms of defence. J Psychopharmacol 5:305–315.
  • MJ Detke, S Wieland, and I Lucki. (1995). Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the forced swim test by 5-HT1A receptor antagonists. Psychopharmacology 119:47–54.
  • MJ Detke, and I Lucki. (1996). Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth. Behav Brain Res 73:43–46.
  • YCF Goulart, AR Santos, JB Calixto, and EA Audi. (2007). Involvement of serotonin in the antidepressant-like effect of extract from Kielmeyera coriacea stems. Pharm Biol 45:1–7.
  • FG Graeff. (1993). Role of 5-HT in defensive behavior and anxiety. Rev Neurosci 4:181–211.
  • SL Handley. (1995). 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmac Thu 66:103–148.
  • S Hjorth, HJ Bengtsson, and S Milano. (1996). Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta–adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. Eur J Pharmacol 316:43–47.
  • S Hjorth, HJ Bengtsson, A Kullberg, D Carlzon, H Peilot, and SB Auerbach. (2000). Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol 14:177–185.
  • PN Karakamus, P Pappas, and M Marselos. (2004). Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: Implication of postsynaptic 5-HT1A receptors. Beh Brain Res 148:199–208.
  • K Linde, G Ramirez, CD Mulrow, A Pauls, W Weidenhammer, and D Melchart. (1996). St. John's wort for depression-an overview and meta-analysis of randomised clinical trials. BMJ 313:253–258.
  • GP Luscombe, KF Martins, LJ Hutchins, J Gosden, and DJ Heal. (1993). Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Br J Pharmacol 108:669–677.
  • JVC Martins, F Otobone, VR Sela, S Obici, MA Tromelli, DAG Cortez, and EA Audi. (2004). Pharmacological activity of lyophilized hydroethanolic extract from Kielmeyera coriacea stems in rats. Acta Scientiarum Health Sci 26:148–153.
  • JVC Martins, FJ Otobone, VR Sela, S Obici, MA Trombelli, DA Garcia Cortez, and EA Audi. (2006). Behavioural tests of fraction from Kielmeyera coriacea stems, in rats. Indian J Pharmacol 38:427–428.
  • G Paxinos, C Watson. (1998): The Rat Brain in Stereotaxic Coordinates. Sidney: Academic Press.
  • G Pineyro, and P Blier. (1999). Autoregulation of serotonin neurons: Role in antidepressant drug action. Pharmacol Rev 51:533–591.
  • RD Porsolt, GDM Anton, and M Jalfre. (1978). Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391.
  • RD Porsolt, M Le Pichon, and M Jalfre. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730–732.
  • JP Redrobe, CP MacSweeney, and M Bourin. (1996). The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol 318:213–220.
  • A Romaniuk, M Koprowska, M Krotewicz, M Strzelczuk, and M Wieczorek. (2001). Effects of 8-OH-DPAT administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats. Behav Brain Res 120:47–57.
  • L Romero, I Hérvas, and F Artigas. (1996a). The 5-HT1A antagonist WAY100635 selectively potentiates the presynaptic effects of serotoninergic antidepressants in rat brain. Neurosc Lett 219:123–126.
  • L Romero, N Bel, F Artigas, C de Montigny, and P Blier. (1996b). Effect of pindolol on the function of pre- and postsynaptic 5HT1A receptors: In vivo microdialysis and eletrophysiological studies in the rat brain. Neuropsychopharmacology 15:349–360.
  • E Tatarczynska, A Klodzinska, and E Chojnacka-Wojcik. (2002). Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Polish J Pharmacol 54:615–623.
  • MD Tricklebank, C Forler, and JR Fozrd. (1984). The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271–282.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.